SCRS drives meaningful change in clinical research through targeted SCRS programs and SCRS Committees connecting sites with industry leaders to remove operational barriers, and advance trial access and innovation in clinical trials across the globe.
IncluDE Program
Advancing Representation in Clinical Trials
The IncluDE Program equips clinical research sites with practical, site-driven tools to recruit participant populations that reflect the real-world patients affected by the conditions being studied, and by advancing health equity and diversity at every stage of the inclusion journey.
Digital Innovation
Guiding Sites Through Trial Technology
The Digital Innovation Initiative gives clinical research sites practical guidance and resources to evaluate, adopt, and manage new trial technologies, reducing operational burden and keeping sites active participants in research’s digital evolution.
Payment Initiative
Improving Trial Payment Transparency
The Payment Initiative is an industry coalition fixing financial pain points for research sites and trial participants alike, by promoting fair compensation and transparent payment processes that support trial success and equitable patient access.
Oncology Program
Empowering Oncology Site Success
The Oncology Program supports clinical research sites as essential partners in the cancer research ecosystem, by helping them navigate operational and regulatory challenges through resources, advocacy, and collaboration.
Cut25
Cut25: Reducing Site Training Burden
Cut25 is an industry-wide initiative led by SCRS calling on pharmaceutical companies, CROs, and technology partners to right-size site training — with a clear, measurable goal: achieve at least a 25% reduction in unnecessary training requirements without sacrificing compliance or quality.
Site Advocacy Groups
Solving Trial Challenges Together
Site Advocacy Groups bring together site professionals and industry leaders to tackle key research challenges. Hosted by sponsors, CROs, or service providers, they create direct dialogue that aligns industry initiatives with site realities.
Public Policy
Bringing the Site Voice Into Federal Policy
The Public Policy Initiative closes the site gap in federal clinical trial policy by putting the operational experience and data of 12,000+ research sites directly in front of FDA, Congress, and reform-shaping institutions, ensuring policy is built on how trials actually run, not just how they’re intended to work on paper.
